 | • レポートコード：GIR-107A12041 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、81ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、アルツハイマー病のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。アルツハイマー病の種類別市場規模（ドネペジル、メマンチン、リバスチグミン）、用途別市場規模（初期～中期段階、中期～後期段階）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・アルツハイマー病の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Allergan、Eisai、Novartis、Daiichi Sankyo、Merz Pharma、Pfizer、Johnson & Johnson、Lundbeck ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ドネペジル、メマンチン、リバスチグミン ・用途別分析2016年-2026年：初期～中期段階、中期～後期段階 ・アルツハイマー病の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・アルツハイマー病のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・アルツハイマー病のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・アルツハイマー病の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・アルツハイマー病の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Alzheimer’s Disease market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Alzheimer’s Disease size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Alzheimer’s Disease market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Alzheimer’s Disease market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Donepezil
Memantine
Rivastigmine
Market segment by Application, can be divided into
Early to Moderate Stages
Moderate to Severe Stages
Market segment by players, this report covers
Allergan
Eisai
Novartis
Daiichi Sankyo
Merz Pharma
Pfizer
Johnson & Johnson
Lundbeck
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Alzheimer’s Disease product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Alzheimer’s Disease, with revenue, gross margin and global market share of Alzheimer’s Disease from 2019 to 2021.
Chapter 3, the Alzheimer’s Disease competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Alzheimer’s Disease market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Alzheimer’s Disease research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Alzheimer’s Disease
1.2 Classification of Alzheimer’s Disease by Type
1.2.1 Overview: Global Alzheimer’s Disease Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Alzheimer’s Disease Revenue Market Share by Type in 2020
1.2.3 Donepezil
1.2.4 Memantine
1.2.5 Rivastigmine
1.3 Global Alzheimer’s Disease Market by Application
1.3.1 Overview: Global Alzheimer’s Disease Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Early to Moderate Stages
1.3.3 Moderate to Severe Stages
1.4 Global Alzheimer’s Disease Market Size & Forecast
1.5 Global Alzheimer’s Disease Market Size and Forecast by Region
1.5.1 Global Alzheimer’s Disease Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Alzheimer’s Disease Market Size by Region, (2016-2021)
1.5.3 North America Alzheimer’s Disease Market Size and Prospect (2016-2026)
1.5.4 Europe Alzheimer’s Disease Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Alzheimer’s Disease Market Size and Prospect (2016-2026)
1.5.6 South America Alzheimer’s Disease Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Alzheimer’s Disease Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Alzheimer’s Disease Market Drivers
1.6.2 Alzheimer’s Disease Market Restraints
1.6.3 Alzheimer’s Disease Trends Analysis
2 Company Profiles
2.1 Allergan
2.1.1 Allergan Details
2.1.2 Allergan Major Business
2.1.3 Allergan Alzheimer’s Disease Product and Solutions
2.1.4 Allergan Alzheimer’s Disease Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Allergan Recent Developments and Future Plans
2.2 Eisai
2.2.1 Eisai Details
2.2.2 Eisai Major Business
2.2.3 Eisai Alzheimer’s Disease Product and Solutions
2.2.4 Eisai Alzheimer’s Disease Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Eisai Recent Developments and Future Plans
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Alzheimer’s Disease Product and Solutions
2.3.4 Novartis Alzheimer’s Disease Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Novartis Recent Developments and Future Plans
2.4 Daiichi Sankyo
2.4.1 Daiichi Sankyo Details
2.4.2 Daiichi Sankyo Major Business
2.4.3 Daiichi Sankyo Alzheimer’s Disease Product and Solutions
2.4.4 Daiichi Sankyo Alzheimer’s Disease Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Daiichi Sankyo Recent Developments and Future Plans
2.5 Merz Pharma
2.5.1 Merz Pharma Details
2.5.2 Merz Pharma Major Business
2.5.3 Merz Pharma Alzheimer’s Disease Product and Solutions
2.5.4 Merz Pharma Alzheimer’s Disease Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Merz Pharma Recent Developments and Future Plans
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Alzheimer’s Disease Product and Solutions
2.6.4 Pfizer Alzheimer’s Disease Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Pfizer Recent Developments and Future Plans
2.7 Johnson & Johnson
2.7.1 Johnson & Johnson Details
2.7.2 Johnson & Johnson Major Business
2.7.3 Johnson & Johnson Alzheimer’s Disease Product and Solutions
2.7.4 Johnson & Johnson Alzheimer’s Disease Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Johnson & Johnson Recent Developments and Future Plans
2.8 Lundbeck
2.8.1 Lundbeck Details
2.8.2 Lundbeck Major Business
2.8.3 Lundbeck Alzheimer’s Disease Product and Solutions
2.8.4 Lundbeck Alzheimer’s Disease Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Lundbeck Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Alzheimer’s Disease Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Alzheimer’s Disease Players Market Share
3.2.2 Top 10 Alzheimer’s Disease Players Market Share
3.2.3 Market Competition Trend
3.3 Alzheimer’s Disease Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Alzheimer’s Disease Revenue and Market Share by Type (2016-2021)
4.2 Global Alzheimer’s Disease Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Alzheimer’s Disease Revenue Market Share by Application (2016-2021)
5.2 Alzheimer’s Disease Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Alzheimer’s Disease Revenue by Type (2016-2026)
6.2 North America Alzheimer’s Disease Revenue by Application (2016-2026)
6.3 North America Alzheimer’s Disease Market Size by Country
6.3.1 North America Alzheimer’s Disease Revenue by Country (2016-2026)
6.3.2 United States Alzheimer’s Disease Market Size and Forecast (2016-2026)
6.3.3 Canada Alzheimer’s Disease Market Size and Forecast (2016-2026)
6.3.4 Mexico Alzheimer’s Disease Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Alzheimer’s Disease Revenue by Type (2016-2026)
7.2 Europe Alzheimer’s Disease Revenue by Application (2016-2026)
7.3 Europe Alzheimer’s Disease Market Size by Country
7.3.1 Europe Alzheimer’s Disease Revenue by Country (2016-2026)
7.3.2 Germany Alzheimer’s Disease Market Size and Forecast (2016-2026)
7.3.3 France Alzheimer’s Disease Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Alzheimer’s Disease Market Size and Forecast (2016-2026)
7.3.5 Russia Alzheimer’s Disease Market Size and Forecast (2016-2026)
7.3.6 Italy Alzheimer’s Disease Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Alzheimer’s Disease Revenue by Type (2016-2026)
8.2 Asia-Pacific Alzheimer’s Disease Revenue by Application (2016-2026)
8.3 Asia-Pacific Alzheimer’s Disease Market Size by Region
8.3.1 Asia-Pacific Alzheimer’s Disease Revenue by Region (2016-2026)
8.3.2 China Alzheimer’s Disease Market Size and Forecast (2016-2026)
8.3.3 Japan Alzheimer’s Disease Market Size and Forecast (2016-2026)
8.3.4 South Korea Alzheimer’s Disease Market Size and Forecast (2016-2026)
8.3.5 India Alzheimer’s Disease Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Alzheimer’s Disease Market Size and Forecast (2016-2026)
8.3.7 Australia Alzheimer’s Disease Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Alzheimer’s Disease Revenue by Type (2016-2026)
9.2 South America Alzheimer’s Disease Revenue by Application (2016-2026)
9.3 South America Alzheimer’s Disease Market Size by Country
9.3.1 South America Alzheimer’s Disease Revenue by Country (2016-2026)
9.3.2 Brazil Alzheimer’s Disease Market Size and Forecast (2016-2026)
9.3.3 Argentina Alzheimer’s Disease Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Alzheimer’s Disease Revenue by Type (2016-2026)
10.2 Middle East & Africa Alzheimer’s Disease Revenue by Application (2016-2026)
10.3 Middle East & Africa Alzheimer’s Disease Market Size by Country
10.3.1 Middle East & Africa Alzheimer’s Disease Revenue by Country (2016-2026)
10.3.2 Turkey Alzheimer’s Disease Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Alzheimer’s Disease Market Size and Forecast (2016-2026)
10.3.4 UAE Alzheimer’s Disease Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Alzheimer's Disease Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Alzheimer's Disease Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Alzheimer's Disease Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Alzheimer's Disease Revenue (USD Million) by Region (2016-2021)
Table 5. Global Alzheimer's Disease Revenue Market Share by Region (2021-2026)
Table 6. Allergan Corporate Information, Head Office, and Major Competitors
Table 7. Allergan Major Business
Table 8. Allergan Alzheimer's Disease Product and Solutions
Table 9. Allergan Alzheimer's Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Eisai Corporate Information, Head Office, and Major Competitors
Table 11. Eisai Major Business
Table 12. Eisai Alzheimer's Disease Product and Solutions
Table 13. Eisai Alzheimer's Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Novartis Corporate Information, Head Office, and Major Competitors
Table 15. Novartis Major Business
Table 16. Novartis Alzheimer's Disease Product and Solutions
Table 17. Novartis Alzheimer's Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Daiichi Sankyo Corporate Information, Head Office, and Major Competitors
Table 19. Daiichi Sankyo Major Business
Table 20. Daiichi Sankyo Alzheimer's Disease Product and Solutions
Table 21. Daiichi Sankyo Alzheimer's Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Merz Pharma Corporate Information, Head Office, and Major Competitors
Table 23. Merz Pharma Major Business
Table 24. Merz Pharma Alzheimer's Disease Product and Solutions
Table 25. Merz Pharma Alzheimer's Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Pfizer Corporate Information, Head Office, and Major Competitors
Table 27. Pfizer Major Business
Table 28. Pfizer Alzheimer's Disease Product and Solutions
Table 29. Pfizer Alzheimer's Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 31. Johnson & Johnson Major Business
Table 32. Johnson & Johnson Alzheimer's Disease Product and Solutions
Table 33. Johnson & Johnson Alzheimer's Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Lundbeck Corporate Information, Head Office, and Major Competitors
Table 35. Lundbeck Major Business
Table 36. Lundbeck Alzheimer's Disease Product and Solutions
Table 37. Lundbeck Alzheimer's Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Global Alzheimer's Disease Revenue (USD Million) by Players (2019-2021)
Table 39. Global Alzheimer's Disease Revenue Share by Players (2019-2021)
Table 40. Breakdown of Alzheimer's Disease by Company Type (Tier 1, Tier 2 and Tier 3)
Table 41. Alzheimer's Disease Players Head Office, Products and Services Provided
Table 42. Alzheimer's Disease Mergers & Acquisitions in the Past Five Years
Table 43. Alzheimer's Disease New Entrants and Expansion Plans
Table 44. Global Alzheimer's Disease Revenue (USD Million) by Type (2016-2021)
Table 45. Global Alzheimer's Disease Revenue Share by Type (2016-2021)
Table 46. Global Alzheimer's Disease Revenue Forecast by Type (2021-2026)
Table 47. Global Alzheimer's Disease Revenue by Application (2016-2021)
Table 48. Global Alzheimer's Disease Revenue Forecast by Application (2021-2026)
Table 49. North America Alzheimer's Disease Revenue by Type (2016-2021) & (USD Million)
Table 50. North America Alzheimer's Disease Revenue by Type (2021-2026) & (USD Million)
Table 51. North America Alzheimer's Disease Revenue by Application (2016-2021) & (USD Million)
Table 52. North America Alzheimer's Disease Revenue by Application (2021-2026) & (USD Million)
Table 53. North America Alzheimer's Disease Revenue by Country (2016-2021) & (USD Million)
Table 54. North America Alzheimer's Disease Revenue by Country (2021-2026) & (USD Million)
Table 55. Europe Alzheimer's Disease Revenue by Type (2016-2021) & (USD Million)
Table 56. Europe Alzheimer's Disease Revenue by Type (2021-2026) & (USD Million)
Table 57. Europe Alzheimer's Disease Revenue by Application (2016-2021) & (USD Million)
Table 58. Europe Alzheimer's Disease Revenue by Application (2021-2026) & (USD Million)
Table 59. Europe Alzheimer's Disease Revenue by Country (2016-2021) & (USD Million)
Table 60. Europe Alzheimer's Disease Revenue by Country (2021-2026) & (USD Million)
Table 61. Asia-Pacific Alzheimer's Disease Revenue by Type (2016-2021) & (USD Million)
Table 62. Asia-Pacific Alzheimer's Disease Revenue by Type (2021-2026) & (USD Million)
Table 63. Asia-Pacific Alzheimer's Disease Revenue by Application (2016-2021) & (USD Million)
Table 64. Asia-Pacific Alzheimer's Disease Revenue by Application (2021-2026) & (USD Million)
Table 65. Asia-Pacific Alzheimer's Disease Revenue by Region (2016-2021) & (USD Million)
Table 66. Asia-Pacific Alzheimer's Disease Revenue by Region (2021-2026) & (USD Million)
Table 67. South America Alzheimer's Disease Revenue by Type (2016-2021) & (USD Million)
Table 68. South America Alzheimer's Disease Revenue by Type (2021-2026) & (USD Million)
Table 69. South America Alzheimer's Disease Revenue by Application (2016-2021) & (USD Million)
Table 70. South America Alzheimer's Disease Revenue by Application (2021-2026) & (USD Million)
Table 71. South America Alzheimer's Disease Revenue by Country (2016-2021) & (USD Million)
Table 72. South America Alzheimer's Disease Revenue by Country (2021-2026) & (USD Million)
Table 73. Middle East & Africa Alzheimer's Disease Revenue by Type (2016-2021) & (USD Million)
Table 74. Middle East & Africa Alzheimer's Disease Revenue by Type (2021-2026) & (USD Million)
Table 75. Middle East & Africa Alzheimer's Disease Revenue by Application (2016-2021) & (USD Million)
Table 76. Middle East & Africa Alzheimer's Disease Revenue by Application (2021-2026) & (USD Million)
Table 77. Middle East & Africa Alzheimer's Disease Revenue by Country (2016-2021) & (USD Million)
Table 78. Middle East & Africa Alzheimer's Disease Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Alzheimer's Disease Picture
Figure 2. Global Alzheimer's Disease Revenue Market Share by Type in 2020
Figure 3. Donepezil
Figure 4. Memantine
Figure 5. Rivastigmine
Figure 6. Alzheimer's Disease Revenue Market Share by Application in 2020
Figure 7. Early to Moderate Stages Picture
Figure 8. Moderate to Severe Stages Picture
Figure 9. Global Alzheimer's Disease Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Alzheimer's Disease Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Alzheimer's Disease Revenue Market Share by Region (2016-2026)
Figure 12. Global Alzheimer's Disease Revenue Market Share by Region in 2020
Figure 13. North America Alzheimer's Disease Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Alzheimer's Disease Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Alzheimer's Disease Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Alzheimer's Disease Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Alzheimer's Disease Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Alzheimer's Disease Market Drivers
Figure 19. Alzheimer's Disease Market Restraints
Figure 20. Alzheimer's Disease Market Trends
Figure 21. Allergan Recent Developments and Future Plans
Figure 22. Eisai Recent Developments and Future Plans
Figure 23. Novartis Recent Developments and Future Plans
Figure 24. Daiichi Sankyo Recent Developments and Future Plans
Figure 25. Merz Pharma Recent Developments and Future Plans
Figure 26. Pfizer Recent Developments and Future Plans
Figure 27. Johnson & Johnson Recent Developments and Future Plans
Figure 28. Lundbeck Recent Developments and Future Plans
Figure 29. Global Alzheimer's Disease Revenue Share by Players in 2020
Figure 30. Alzheimer's Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 31. Global Top 3 Players Alzheimer's Disease Revenue Market Share in 2020
Figure 32. Global Top 10 Players Alzheimer's Disease Revenue Market Share in 2020
Figure 33. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 34. Global Alzheimer's Disease Revenue Share by Type in 2020
Figure 35. Global Alzheimer's Disease Market Share Forecast by Type (2021-2026)
Figure 36. Global Alzheimer's Disease Revenue Share by Application in 2020
Figure 37. Global Alzheimer's Disease Market Share Forecast by Application (2021-2026)
Figure 38. North America Alzheimer's Disease Sales Market Share by Type (2016-2026)
Figure 39. North America Alzheimer's Disease Sales Market Share by Application (2016-2026)
Figure 40. North America Alzheimer's Disease Revenue Market Share by Country (2016-2026)
Figure 41. United States Alzheimer's Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Canada Alzheimer's Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Mexico Alzheimer's Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Europe Alzheimer's Disease Sales Market Share by Type (2016-2026)
Figure 45. Europe Alzheimer's Disease Sales Market Share by Application (2016-2026)
Figure 46. Europe Alzheimer's Disease Revenue Market Share by Country (2016-2026)
Figure 47. Germany Alzheimer's Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Alzheimer's Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Alzheimer's Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Alzheimer's Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Alzheimer's Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Alzheimer's Disease Sales Market Share by Type (2016-2026)
Figure 53. Asia-Pacific Alzheimer's Disease Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Alzheimer's Disease Revenue Market Share by Region (2016-2026)
Figure 55. China Alzheimer's Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Alzheimer's Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. South Korea Alzheimer's Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Alzheimer's Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Alzheimer's Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Alzheimer's Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Alzheimer's Disease Sales Market Share by Type (2016-2026)
Figure 62. South America Alzheimer's Disease Sales Market Share by Application (2016-2026)
Figure 63. South America Alzheimer's Disease Revenue Market Share by Country (2016-2026)
Figure 64. Brazil Alzheimer's Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Argentina Alzheimer's Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Middle East and Africa Alzheimer's Disease Sales Market Share by Type (2016-2026)
Figure 67. Middle East and Africa Alzheimer's Disease Sales Market Share by Application (2016-2026)
Figure 68. Middle East and Africa Alzheimer's Disease Revenue Market Share by Country (2016-2026)
Figure 69. Turkey Alzheimer's Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Saudi Arabia Alzheimer's Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. UAE Alzheimer's Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Methodology
Figure 73. Research Process and Data Source
世界のアルツハイマー病治療市場予測（～2024年）：企業別、地域別、種類・用途別 Alzheimer's is a chronic neurodegenerative disease that usually starts slowly and worsens over time. Scope of the Report: The global Alzheimer's Disease Treatments market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between …- 世界のアルツハイマー病治療薬市場予測（～2024年）：メーカー別、地域別、種類・用途別 Alzheimer's is a chronic neurodegenerative disease that usually starts slowly and worsens over time. Scope of the Report: The worldwide market for Alzheimer's Disease Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ i…
- 世界の性感染症治療市場 2021：企業別、地域別、種類・用途別 The Sexually Transmitted Disease Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…
- 世界の網膜疾患治療市場 2021：企業別、地域別、種類・用途別 The Retinal Disease Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 世界のレイノー病治療市場 2021：企業別、地域別、種類・用途別 The Raynauds Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…